HomeInsightsPE

Bacil Pharma Ltd P/E Ratio

Bacil Pharma Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

3.8 K

stocks traded

Last Updated time: 18 Jul 15:30 PM

Image

Bacil Pharma Ltd

NSE: BACILPHARMA

PE

0

Last updated : 18 Jul 15:30 PM

Key Highlights

    The P/E Ratio of Bacil Pharma Ltd is 0 as of 18 Jul 15:30 PM .a1#The P/E Ratio of Bacil Pharma Ltd changed from 0 on March 2019 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#The Latest Trading Price of Bacil Pharma Ltd is ₹ 19.85 as of 18 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Finance industry is 24.5. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Pharmaceuticals industry is 36.7. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.5. In 2024a1#The Market Cap of Bacil Pharma Ltd changed from ₹ 0.97 crore on March 2019 to ₹ 3.23 crore on March 2023 . This represents a CAGR of 35.09% over 4 years. a1#The Revenue of Bacil Pharma Ltd changed from ₹ 0.07 crore to ₹ 0.02 crore over 8 quarters. This represents a CAGR of -46.55% a1#The EBITDA of Bacil Pharma Ltd changed from ₹ 0.02 crore to ₹ -0.04 crore over 8 quarters. This represents a CAGR of NaN% a1#The Net Pr of Bacil Pharma Ltd changed from ₹ 0.02 crore to ₹ -0.04 crore over 8 quarters. This represents a CAGR of NaN% a1#The Dividend Payout of Bacil Pharma Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Bacil Pharma Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Bacil Pharma Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

Company Fundamentals for Bacil Pharma Ltd

Market Cap

11 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

20.3

Day’s High

20.37

Day’s Low

18.98

DTE *

0.1

ROE *

-4.9

52 Week High

29.21

52 Week Low

4.68

ROCE *

-4.5

* All values are consolidated

Last Updated time: 18 Jul 15:30 PM

* All values are consolidated

Last Updated time: 18 Jul 15:30 PM

Image

Bacil Pharma Ltd

NSE: BACILPHARMA

PRICE

19.85

-0.12 (-0.60%)

stock direction

Last updated : 18 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Bacil Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Bacil Pharma Ltd

Market Value

12

Asset Value

0

77.4 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Bacil Pharma Ltd011
Sun Pharmaceuticals Industries Ltd37378,915
Cipla Ltd28122,044
Divis Laboratories Ltd75121,185
Zydus Lifesciences Ltd30119,224
Dr Reddys Laboratories Ltd20110,827

Key Valuation Metric of Bacil Pharma Ltd

Earnings

-0 Cr

0.0 X

PE Ratio

Market Cap

₹11.76Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

-0 Cr

0.0 X

PE Ratio

Market Cap

₹11.76Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Bacil Pharma Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Bacil Pharma Ltd

Period
Mar '190
Mar '201
Mar '212
Mar '223
Mar '233

* All values are a in crore

×

Historical Revenue of Bacil Pharma Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Bacil Pharma Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical EBITDA of Bacil Pharma Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Bacil Pharma Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical Net Profit of Bacil Pharma Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Bacil Pharma Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical Dividend Payout of Bacil Pharma Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Bacil Pharma Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Bacil Pharma Ltd

About Bacil Pharma Ltd

    Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs. Domestic operations are spread across pan India. The company has strong field force of 500 plus, spread over various States and Districts. It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage. To augment the domestic market, Company's operations are based on focused approach. Multi-Speciality division Vibrant specialises in various specialties, like Anti-Infectives, Pain Management, Respiratory Care, Women's Health, to name a few. Aziwin, Ebay, Balvibe, MNF, Ocium and Monogesic Plus Gel (Innovative Pain Relieving Gel, first time in India) are some of the leading brands in the respective segments. Bal Vedics Division integrates modern medicine with herbal/ayurvedic preparation targeting specific conditions like, Prostrate Enlargement, Renal Calculi, Male Infertility, Women Health etc. Bal Pharma Institutional division is associated with the top Government bodies and Hospitals to extend its product range to the masses. Every area is well covered and supplied through there channel partners. Bal Pharma Unit - 1, is a finished dosage facility for manufacturing Tablets and Capsules. Bal Pharma Unit - 2, is involved in the manufacturing of APIs. A well-equipped R&D laboratory, a good Kilo laboratory and quality control facilities form the other spheres of activity here. Bal Pharma Unit - 3, is a finished dosage facility for manufacturing Intravenous Fluids, Ophthalmic Preparations & Liquid Oral Preparations. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol, norfloxacin, pefloxacin and ciprofloxacin. The company entered into a marketing arrangement with a distributor Kam Han Industries, Hong Kong, to export 50% of the production. Due to various reasons, the civil works at Vapi were affected. However, to avoid further delay in project implementation, the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri).

Bacil Pharma Ltd News Hub

News

Bacil Pharma to convene board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 21 May 2024 P...

Read more

15 May 202415:28

News

Bacil Pharma to hold board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 13 February 2...

Read more

03 Feb 202419:31

News

Bacil Pharma to declare Quarterly Result

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 10 November 2...

Read more

04 Nov 202310:36

News

Bacil Pharma AGM scheduled

Bacil Pharma announced that the 36th Annual General Meeting (AGM) of the company will be h...

Read more

26 Aug 202311:47

News

Bacil Pharma to declare Quarterly Result

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 14 August 202...

Read more

10 Aug 202311:25

News

Bacil Pharma to declare Quarterly Result

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 16 May 2023. ...

Read more

09 May 202312:03

Product Composition by Percentage (Revenue)

FAQs for PE of Bacil Pharma Ltd

What is Bacil Pharma Ltd current share price?

The current market price of Bacil Pharma Ltd as of July 18, 2024 is ₹19.85.

What is Bacil Pharma Ltd's market cap?

Bacil Pharma Ltd's market capitalisation stood at ₹11 Cr as of July 18, 2024

What are Bacil Pharma Ltd's total net assets?

According to Bacil Pharma Ltd's most recent financial filings, the company's net assets total ₹0.2 Cr.

Is Bacil Pharma Ltd making a profit or loss?

Bacil Pharma Ltd's net Profit as of July 18, 2024 is close to ₹0 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199